It’s time for ALS drugs that work
We’ve come a long way in our understanding of ALS—but there are still no treatments that make a meaningful difference in this devastating disease.
The Core leverages the best of non-profit advocacy and world-class academic research toward better ALS drug development. Founded and funded by Project ALS, The Core integrates world-leading neuroscience expertise at Columbia’s Motor Neuron Center with patient-driven clinical research at the Eleanor and Lou Gehrig ALS Center to develop new ALS therapies, evaluate promising drug candidates comprehensively and efficiently, and move top performers to people as quickly as possible.
The Core begins and ends with ALS patients. We rely on blood samples to develop better disease biomarkers and cellular models for drug screening—and we will deliver more humane and informative clinical trials back to people with ALS.